fingolimod medical valley 0,5 mg kapsel, hård
medical valley invest ab - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans
fingolimod unimedic pharma 0,5 mg kapsel, hård
unimedic pharma ab - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans
fingolimod avansor 0,5 mg kapsel, hård
avansor pharma oy - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans
fingolimod stada 0,5 mg kapsel, hård
stada arzneimittel ag - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans
fingolimod teva 0,5 mg kapsel, hård
teva gmbh - fingolimodhydroklorid - kapsel, hård - 0,5 mg - propylenglykol hjälpämne; natriumlaurilsulfat hjälpämne; fingolimodhydroklorid 0,56 mg aktiv substans
fingolimod teva 0,25 mg kapsel, hård
teva gmbh - fingolimodhydroklorid - kapsel, hård - 0,25 mg - natriumlaurilsulfat hjälpämne; propylenglykol hjälpämne; fingolimodhydroklorid 0,28 mg aktiv substans
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcell - antineoplastiska medel - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
fingolimod glenmark 0,5 mg kapsel, hård
glenmark pharmaceuticals nordic ab - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans
fingolimod orion 0,5 mg kapsel, hård
orion corporation - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans; propylenglykol hjälpämne
fingolimod zentiva 0,5 mg kapsel, hård
zentiva k.s. - fingolimodhydroklorid - kapsel, hård - 0,5 mg - fingolimodhydroklorid 0,56 mg aktiv substans